MoonLake Immunotherapeutics (MLTX) market cap

Market cap today
$957.45M

MoonLake Immunotherapeutics (MLTX) has a market cap of $957.45M. At the end of fiscal 2025 (December 31, 2025) its market cap was $849.63M. That is 75.0% lower than the $3.40B of fiscal 2024. Today's figure is 12.7% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 12:04 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$957.45M
Market cap, fiscal 2025
$849.63M
Change on fiscal 2024
−75.0%
Highest on record
$3.56Bfiscal 2021
Lowest on record
$409.26Mfiscal 2022
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

MoonLake Immunotherapeutics market cap, in more detail

Across the 5 fiscal year-ends on record (2021–2025), the highest was $3.56B in fiscal 2021 and the lowest $409.26M in fiscal 2022.

History · 5 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

MoonLake Immunotherapeutics market cap, year by year

MoonLake Immunotherapeutics (MLTX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$957.45M—$11.25—
2025$849.63M 75.0% down$13.1864.46M
2024$3.40B 14.8% up$54.1562.87M
2023$2.97B 624.8% up$60.3949.12M
2022$409.26M 88.5% down$10.5038.98M
2021$3.56B—$9.89360.00M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on MLTX

MoonLake Immunotherapeutics, figure by figure

MoonLake Immunotherapeutics (MLTX) overview: price, valuation and scorecard

MoonLake Immunotherapeutics market cap: questions and answers

What is MoonLake Immunotherapeutics's market cap?

MoonLake Immunotherapeutics (MLTX) has a market cap of $957.45M. At the end of fiscal 2025 (December 31, 2025) its market cap was $849.63M. That is 75.0% lower than the $3.40B of fiscal 2024.

What are the highest and lowest market cap figures on record for MoonLake Immunotherapeutics?

Across the 5 fiscal year-ends on record (2021–2025), the highest was $3.56B in fiscal 2021 and the lowest $409.26M in fiscal 2022.

How is MoonLake Immunotherapeutics's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For MoonLake Immunotherapeutics it is on record here for 5 fiscal years, 2021 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “MoonLake Immunotherapeutics (MLTX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/MLTX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.